The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Valganciclovir 450mg Film-coated Tablets

450 milligram(s) Film-coated tablet

McDermott Laboratories Ltd t/a Gerard LaboratoriesPA0577/215/001

Main Information

Trade NameValganciclovir 450mg Film-coated Tablets
Active SubstancesValganciclovir
Strength450 milligram(s)
Dosage FormFilm-coated tablet
Licence HolderMcDermott Laboratories Ltd t/a Gerard Laboratories
Licence NumberPA0577/215/001

Group Information

ATC CodeJ05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors
J05AB14 valganciclovir


Licence Issued30/01/2015
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back